| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Endocrinology (B.C., C.P., J.G., A-F. B., F.M.-J.), Institut National de la Santé et de la Recherche Médicale, Unité 567-Centre National de la Recherche Scientifique (CNRS), Unité Mixte de Recherche (UMR) 8104, Cochin Institute, Paris 75014, France; Department of Endocrinology and Diabetes (P.B., F.M.-J.), Department of Hormonal Biochemistry and University of Paris VII School of Medicine, Saint-Louis Hospital, Paris 75010, France; CNRS-UMR 5018 (R.B.), Paul Sabatier University, Toulouse 31062, France; and Research Division (C.R.K.), Joslin Diabetes Center, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02215
Address all correspondence and requests for reprints to: Franck Mauvais-Jarvis, M.D., Ph.D., Department of Medicine, Division of Diabetes, Endocrinology & Metabolism, Baylor College of Medicine, Room 520B, Houston, Texas 77030. E-mail: fmjarvis{at}bcm.tmc.edu.
White adipose tissue (WAT) plays a critical role in the development of insulin resistance via secretion of free fatty acids (FFA) and adipocytokines. Muscle-specific insulin receptor knockout (MIRKO) mice do not develop insulin resistance or diabetes under physiological conditions despite a marked increase in adiposity and plasma FFA. On the contrary, WAT of MIRKO is sensitized to insulin action during a euglycemic clamp, and WAT glucose utilization is dramatically increased. To get insight into the potential antidiabetic role of MIRKO adiposity, we have studied insulin action in WAT during a euglycemic, hyperinsulinemic clamp, and we have characterized the morphology and biology of WAT. During the clamp, there is no alteration in the expression or activation in the insulin signaling molecules involved in glucose transport through the phosphoinositide 3-kinase/Akt and CAP/Cbl pathways in WAT from MIRKO. The 53% increase in WAT mass results from a 48% increase in adipocyte number (P < 0.05) without alteration in cell size and contemporary to a 300% increase in mRNA levels of the adipogenic transcription factor CCAAT enhancer binding protein-
(C/EBP-
) (P < 0.05). There is a 39.5% increase in serum adiponectin (P < 0.01) without modification in serum leptin, resistin, and TNF-
. In conclusion, the MIRKO mouse displays muscle insulin resistance, visceral obesity, and dyslipidemia but does not develop hyperinsulinemia or diabetes. There is an accelerated differentiation of small insulin sensitive adipocytes, an increased secretion of the insulin sensitizer adiponectin, and maintenance of leptin sensitivity. The MIRKO mouse confirms the importance of WAT plasticity in the maintenance of whole body insulin sensitivity and represents an interesting model to search for new secreted molecules that positively alter adipose tissue biology.
This article has been cited by other articles:
![]() |
K. N. Ealey, S. Lu, D. Lau, and M. C. Archer Reduced susceptibility of muscle-specific insulin receptor knockout mice to colon carcinogenesis Am J Physiol Gastrointest Liver Physiol, March 1, 2008; 294(3): G679 - G686. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. J. Leunissen, P. Oosterbeek, L. K. M. Hol, A. A. Hellingman, T. Stijnen, and A. C. S. Hokken-Koelega Fat Mass Accumulation during Childhood Determines Insulin Sensitivity in Early Adulthood J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 445 - 451. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Delibegovic, K. K. Bence, N. Mody, E.-G. Hong, H. J. Ko, J. K. Kim, B. B. Kahn, and B. G. Neel Improved Glucose Homeostasis in Mice with Muscle-Specific Deletion of Protein-Tyrosine Phosphatase 1B Mol. Cell. Biol., November 1, 2007; 27(21): 7727 - 7734. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ranalletta, X. Q. Du, Y. Seki, A. S. Glenn, M. Kruse, A. Fiallo, I. Estrada, T.-S. Tsao, A. E. Stenbit, E. B. Katz, et al. Hepatic response to restoration of GLUT4 in skeletal muscle of GLUT4 null mice Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1178 - E1187. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Serino, R. Menghini, L. Fiorentino, R. Amoruso, A. Mauriello, D. Lauro, P. Sbraccia, M. L. Hribal, R. Lauro, and M. Federici Mice Heterozygous for Tumor Necrosis Factor-{alpha} Converting Enzyme Are Protected From Obesity-Induced Insulin Resistance and Diabetes Diabetes, October 1, 2007; 56(10): 2541 - 2546. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Qiao and J. Shao SIRT1 Regulates Adiponectin Gene Expression through Foxo1-C/Enhancer-binding Protein {alpha} Transcriptional Complex J. Biol. Chem., December 29, 2006; 281(52): 39915 - 39924. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Semple, M. A. Soos, J. Luan, C. S. Mitchell, J. C. Wilson, M. Gurnell, E. K. Cochran, P. Gorden, V. K. K. Chatterjee, N. J. Wareham, et al. Elevated Plasma Adiponectin in Humans with Genetically Defective Insulin Receptors J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3219 - 3223. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Ayala, D. P. Bracy, O. P. McGuinness, and D. H. Wasserman Considerations in the Design of Hyperinsulinemic-Euglycemic Clamps in the Conscious Mouse Diabetes, February 1, 2006; 55(2): 390 - 397. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Pederson, J. M. Schroeder, G. E. Parker, M. W. Smith, A. A. DePaoli-Roach, and P. J. Roach Glucose Metabolism in Mice Lacking Muscle Glycogen Synthase Diabetes, December 1, 2005; 54(12): 3466 - 3473. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Plum, F. T. Wunderlich, S. Baudler, W. Krone, and J. C. Bruning Transgenic and Knockout Mice in Diabetes Research: Novel Insights into Pathophysiology, Limitations, and Perspectives Physiology, June 1, 2005; 20(3): 152 - 161. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |